Ulixacaltamide

Name: Ulixacaltamide in Essential tremor: Care management intervention strategies
Published: 2026-09-14T15:39:06-04:00

Essential tremor

Manufacturer: Praxis Precision Medicines
Regulatory submission: NDA submitted by February 2026
Launch: Not announced
Last updated: September 19, 2026

Section

Product information and disease description Place of product in therapy Approaches to treatment

Care management intervention strategies

1 evidence topic · 1 source

Patient and caregiver psychosocial support

“address patient embarrassment and perceived embarrassment to better support caregivers and ET patients.” (opens the source at this quote in a new tab)